You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
CARTO PRIME® Module
CARTO PRIME® Module
CARTO® 3 System Version 7 and the CARTO PRIME® Module offers advancement in 3D mapping technology. From signals to diagnosis, across a wide range of electrophysiology procedures, we are re-framing the future of electrophysiology.
Features & Benefits
Coherent Mapping
Benefits:
Coherent Mapping may simplify the diagnosis of scar‐related complex atrial arrhythmia by applying physiological constraints on LAT information. Improves accuracy of ablation site identification1
Features:
- Conduction ID
- Conduction velocity vectors
- Conduction barrier zones; such as scar, slow conduction and anatomical structures
CARTOFINDER ™ Module
Benefits:
Conveniently identifies repetitive focal and rotational region of interest in adjunction with your current AFib workflow.2
Features:
- Automatic visualization of region of interest
LAT Hybrid
Benefits:
Improves location accuracy compared with standard PVC mapping by associating the PVC location information to its corresponding normal sinus rhythm location.3
Features:
- Correct ID of PVC location based on catheter location in sinus rhythm Automated visualization of PVC points
Parallel Mapping and Map Replay
Benefits:
Efficiency gain of mapping multiple arrhythmias prospectively or retrospectively
Features:
- Prospectively map up to 4 different arrythmias at the same time
- Ability to create maps retrospectively in a few seconds based on recorded data and acquired points
References
1. Anter E et al. Activation Mapping with Integration of Vector and Velocity Information Improves the Ability to Identify the Mechanism and Location of Complex Scar Related Atrial Tachycardias. Circ Arrhythm Electrophysiol. 2018;11:e006536.
2. Bench testing performed by Biosense Webster, Inc. CARTO® 3 V7 CARTOFINDER Algorithm POD Report February 2019.
3. Steyers III CM et al. Ablation using 3D maps adjusted for spatial displacement of premature ventricular complexes relative to sinus beats: Improving precision by correcting for the shift. J Cardiovasc Electrophysiol. 2019;1–7.
* CARTO PRIME® Module kit requires CONFIDENSE® Module and CARTOREPLAY™ Module as prerequisite
** CARTO® 3 System Version 7 base requires CONFIDENSE® Module as prerequisite
Important information: Prior to use, refer to the instructions for use supplied with this device for indications, contraindications, side effects, warnings and precautions. Caution: US law restricts this device to sale by or on the order of a physician.
THERMOCOOL® Navigation Catheters are indicated for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with CARTO® 3 Systems (excluding NAVISTAR® RMT THERMOCOOL® Catheter). THERMOCOOL® Navigation Catheters are indicated for the treatment of recurrent drug/device refractory sustained monomorphic ventricular tachycardia (VT) due to prior myocardial infarction (MI) in adults.
139469-200507
Last Updated on 6/29/2020
This site is published by Biosense Webster, Inc. which is solely responsible for its contents. It is intended for visitors from the United States.